English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Hyperphosphatemia is a pervasive problem among dialysis patients with end stage kidney disease (ESKD). It has been associated with high morbidity, mortality and hospitalization rate (1). The abnormalities of the phosphate metabolism in these patients can leads to cardiovascular calcification, renal osteodystrophy and secondary hyperparathyroidism (2-6). Therefore, correction of phosphate level is a major goal in the management of hyperphosphatemia among ESKD patients.

easterns journal of medicine/eastern journal of medicine

Effectiveness of self-adjusted phosphate binder dose according to dietary phosphate content method in improving hyperphosphatemia among hemodialysis patients